Fred Hutchinson Cancer Center
The Post-Doctoral Research Fellow at Fred Hutchinson Cancer Center will explore how dysregulation of chromatin modifying enzymes and developmental pathways contribute to pancreas and biliary cancer pathogenesis. The role involves generating and utilizing various cancer model systems to understand fundamental pathogenic mechanisms. The fellow will work within the Kugel Laboratory to identify potential liabilities in the tumor microenvironment for cancer therapy.
Fred Hutchinson Cancer Center is a nonprofit research and treatment organization dedicated to eliminating cancer and related diseases. It combines laboratory research, clinical trials, and patient care to improve prevention and treatment across cancers as well as related conditions such as HIV/AIDS and autoimmune diseases. Fred Hutch provides comprehensive patient services (appointments, MyChart, provider and referral resources) and works closely with physicians and partner institutions to translate discoveries into new therapies. The center is known for rigorous science and integrated clinical programs that move innovations from bench to bedside.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fred Hutchinson Cancer Center.